Michael Morrison
YOU?
Author Swipe
View article: Ethics Review of AI research: An approach to reviewing and revising existing governance structures
Ethics Review of AI research: An approach to reviewing and revising existing governance structures Open
The recent advancements in artificial intelligence (AI), and data science more broadly, have led to a proliferation of new methods and tools, such as machine learning (ML), that are used in all kinds of scientific research, from biomedical…
View article: Ethical and social considerations of applying artificial intelligence in healthcare—a two-pronged scoping review
Ethical and social considerations of applying artificial intelligence in healthcare—a two-pronged scoping review Open
Background Artificial Intelligence (AI) is being designed, tested, and in many cases actively employed in almost every aspect of healthcare from primary care to public health. It is by now well established that any application of AI carrie…
View article: Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies
Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies Open
Next-generation vaccine delivery technologies may provide significant gains from both a technical and behavioral standpoint, but no scale has yet been developed to assess public attitudes to novel vaccine delivery technologies. We therefor…
View article: Participation in SoHO and ATMP public consultations: a fragmented institutional landscape
Participation in SoHO and ATMP public consultations: a fragmented institutional landscape Open
In the European Union (EU), the recent adoption of the Substances of Human Origin (SoHO) Regulation in June 2024 brings into force new harmonised rules for human cells, tissues and blood. This legislation interacts with the pre-existing Ad…
View article: Oxford Vaccine Hesitancy Scale (OVHS): a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess vaccine hesitancy
Oxford Vaccine Hesitancy Scale (OVHS): a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess vaccine hesitancy Open
Objectives To describe the development, validation and reliability of the Oxford Vaccine Hesitancy Scale (OVHS), a new instrument to assess vaccine hesitancy in the general population. Design Cross-sectional validation study. Setting Inter…
View article: The Oxford Needle Experience (ONE) scale: a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess needle fear, attitudes and expectations in the general public
The Oxford Needle Experience (ONE) scale: a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess needle fear, attitudes and expectations in the general public Open
Objectives To develop and validate the Oxford Needle Experience (ONE) scale, an instrument to assess needle fear, attitudes and expectations in the general population. Design Cross-sectional validation study. Setting Internet-based with pa…
View article: Report from the "Governing Biomodification" (BioGov) End of Project workshop July 2022
Report from the "Governing Biomodification" (BioGov) End of Project workshop July 2022 Open
The aim of the project “Governing biomodification in the life sciences” (‘BioGOV’) was to assess the regulatory framework for three emerging ‘biomodifying’ technologies: gene editing, induced pluripotent stem cells and 3D bioprinting. Each…
View article: Editorial: Regulation and governance of gene editing technologies (CRISPR, etc.)
Editorial: Regulation and governance of gene editing technologies (CRISPR, etc.) Open
EDITORIAL article Front. Polit. Sci., 20 September 2022Sec. Politics of Technology Volume 4 - 2022 | https://doi.org/10.3389/fpos.2022.1027410
View article: Making translational value: Identifying ‘good targets’ for clinical research on gene editing and induced pluripotent stem cell technologies
Making translational value: Identifying ‘good targets’ for clinical research on gene editing and induced pluripotent stem cell technologies Open
Biomedical translational researchers aim to develop knowledge and techniques arising from research in the life sciences into clinical applications. Using the examples of induced pluripotent stem cells (iPSC) and gene editing, this paper ex…
View article: Patent power in biomedical innovation: Technology governance in biomodifying technologies
Patent power in biomedical innovation: Technology governance in biomodifying technologies Open
Biomedical innovation is often rewarded by exclusive proprietary rights such as patents. In the case of gene editing, induced pluripotent stem cells, and three‐dimensional (3D) bioprinting (here described as biomodifying technologies), the…
View article: Biomodifying the ‘natural’: from Adaptive Regulation to Adaptive Societal Governance
Biomodifying the ‘natural’: from Adaptive Regulation to Adaptive Societal Governance Open
Biomodifying technologies—such as gene editing, induced pluripotent stem cells, and bioprinting—are being developed for a wide range of applications, from pest control to lab-grown meat. In medicine, regulators have responded to the challe…
View article: Comparative Lessons in Regenerative Medicine Readiness: Learning From the UK and Japanese Experience
Comparative Lessons in Regenerative Medicine Readiness: Learning From the UK and Japanese Experience Open
This paper explores how 'regenerative readiness' varies between different national research and healthcare systems. Here, 'readiness' refers to both the readiness of a given technology and the ability of a given setting to adopt a new tech…
View article: Spatiotemporal Readiness is Key to Preparing Regenerative Medicine for the Clinic
Spatiotemporal Readiness is Key to Preparing Regenerative Medicine for the Clinic Open
Tweetable abstract Successful translation of regenerative medicine projects to the clinic requires attention to the complex interaction of spatial and timing issues from manufacturing to clinical use.